Hydroxocobalamin Alternova (Hydroxocobalamin Chloride)

Hydroxocobalamin serves as a precursor to the active coenzyme forms methylcobalamin and adenosylcobalamin. These cofactors are essential for enzymes such as methionine synthase and methylmalonyl‑CoA mutase, which support DNA synthesis, red blood cell formation, and myelin production. In cyanide poisoning, hydroxocobalamin directly binds cyanide to form cyanocobalamin, which is safely excreted.

The specific dose and administration schedule of Hydroxocobalamin Alternova are determined by the prescribing clinician based on the patient’s condition, severity, and clinical response. Healthcare professionals should follow local guidelines and product labeling when prescribing.

Safety data for Hydroxocobalamin Alternova in pregnancy and lactation are limited. It should only be used when clearly needed, after a careful risk‑benefit assessment by the treating physician. Breastfeeding mothers should consult their healthcare provider before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required), and import documentation.

Hydroxocobalamin is a natural, long‑acting form of vitamin B12 that can be converted to both methylcobalamin and adenosylcobalamin, offering broader metabolic support than cyanocobalamin. It also has the unique ability to act as a cyanide antidote, a property not shared by most other B12 preparations.

Hydroxocobalamin Alternova should be stored at 2‑8 °C (refrigerated). Keep the vials in their original packaging, protect them from light, and avoid freezing or shaking the solution to maintain stability.

The product is supplied as an injectable solution for intramuscular injection. Administration is performed by a qualified healthcare professional using aseptic technique, typically into the deltoid or gluteal muscle, according to the prescribing information.

Serious adverse reactions, although rare, include anaphylaxis, severe hypotension, hemolytic anemia, and pulmonary edema. Immediate medical attention is required if any signs of a severe allergic reaction or cardiovascular compromise occur after administration.

Patients with a known hypersensitivity to hydroxocobalamin or any component of the formulation should avoid this product. Caution is also advised for individuals with severe renal impairment, and it should be used only when clearly indicated in pregnant or breastfeeding women.